PT - JOURNAL ARTICLE AU - Wang, Shuai AU - Kang, Bo AU - Ma, Jinlu AU - Zeng, Xianjun AU - Xiao, Mingming AU - Guo, Jia AU - Cai, Mengjiao AU - Yang, Jingyi AU - Li, Yaodong AU - Meng, Xiangfei AU - Xu, Bo TI - A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19) AID - 10.1101/2020.02.14.20023028 DP - 2020 Jan 01 TA - medRxiv PG - 2020.02.14.20023028 4099 - http://medrxiv.org/content/early/2020/02/17/2020.02.14.20023028.short 4100 - http://medrxiv.org/content/early/2020/02/17/2020.02.14.20023028.full AB - The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) has caused approximately 64,000 cases of Corona Virus Disease (COVID-19) in China so far, with that number continuing to grow. To control the spread of the disease, screening large numbers of suspected cases for appropriate quarantine and treatment measures is a priority. Viral nucleic acid testing based on specimens from the lower respiratory tract is the diagnostic gold standard. However, the availability and quality of laboratory testing in the infected region presents a challenge,so alternative diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we hypothesized that Artificial Intelligence’s deep learning methods might be able to extract COVID-19’s specific graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control. To test this possibility, we collected 453 CT images of pathogen-confirmed COVID-19 cases along with previously diagnosed with typical viral pneumonia. 217 images were used as the training set and the inception migration-learning model was used to establish the algorithm. The internal validation achieved a total accuracy of 82.9% with specificity of 80.5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73.1% with specificity of 67% and sensitivity of 74%. These results indicate the great value of using the deep learning method to extract radiological graphical features for COVID-19 diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available. https://ai.nscc-tj.cn/thai/deploy/public/pneumonia_ct